Ignite Creation Date:
2025-12-25 @ 4:03 AM
Ignite Modification Date:
2026-01-28 @ 9:24 PM
Study NCT ID:
NCT05940402
Status:
COMPLETED
Last Update Posted:
2025-04-04
First Post:
2023-07-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Evaluate Pharmacokinetic and Safety Trial of Emraclidine in Participants With Renal Impairment Compared With Participants With Normal Renal Function
Sponsor:
AbbVie
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-07-24
Start Date Type:
ACTUAL
Primary Completion Date:
2024-12-19
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-12-19
Completion Date Type:
ACTUAL
First Submit Date:
2023-07-02
First Submit QC Date:
None
Study First Post Date:
2023-07-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-04-02
Last Update Post Date:
2025-04-04
Last Update Post Date Type:
ACTUAL